Joseph Donahue is an end-to-end drug development professional with over 15 years of biotech and CRO experience. Joseph has extensive product development experience encompassing clinical operations, study implementation, program strategy and design for small-molecules, biologics and gene therapies. He has worked across multiple therapeutic areas including autoimmune and inflammatory disease, rare disease, oncology and cardiovascular disease through all phases of the product development lifecycle. Joe has held positions of increasing responsibility within Clinical Operations at Parexel, Curis Inc and Homology Medicines. He received his Bachelor of Science degree from Roger Williams University.